NONMEM Users Network Archive

Hosted by Cognigen

Re: Free speed consulting with Pharmetheus at PAGE in Stockholm

From: Jakob Ribbing <jakob.ribbing>
Date: Wed, 29 May 2019 17:03:02 +0200

Dear all,

In case you are attending PAGE, and have not yet signed up for the free =
speed consulting with Pharmetheus, you are still most welcome to do so!

If there is anything you would like to discuss, feel free to set up a =
meeting with us, even if you have no plans to use our consultancy =
services later - this is open to everyone.

Please use this link to get in contact with us for this matter: =

Looking forward to seeing you at PAGE!


Jakob Ribbing, Ph.D.

Senior Consultant, Pharmetheus AB

Cell/Mobile: +46 (0)70 514 33 77

Jakob.Ribbing <>

Phone, Office: +46 (0)18 513 328

Uppsala Science Park, Dag Hammarskjölds väg 36B

SE-752 37 Uppsala, Sweden

> On 21 May 2019, at 10:36, Martin Bergstrand =
> Free speed consulting with Pharmetheus at PAGE in Stockholm
> Due to its popularity last year, Pharmetheus will again offer free =
> consulting at the PAGE Meeting in Stockholm, Sweden. Pharmetheus will
> offer professional pharmacometric consulting sessions (~30 min), free =
> charge. Note that these sessions are open to everyone and independent =
> any current or future plans to use our services.
> Pharmetheus’ senior experts are available to give input on a =
wide range of
> pharmacometric topics, offering strategic as well as hands-on =
> concerning small as well as large molecules and drug projects in all
> development phases. Examples of topics below (not limited to):
> - Study/experimental design (e.g. optimal design, clinical trial
> simulations and adaptive design methodology)
> - Pharmacometrics analysis methodology (e.g. covariate model building =
> model qualification)
> - Physiology based pharmacokinetics (PBPK) modelling
> - Model-informed drug development (MIDD) strategy
> - Regulatory strategy for clinical pharmacology and pharmacometric
> analysis
> - Pediatric drug development
> - Data programming
> - Pharmacometric approaches to analyse discreet data (e.g. =
> and count data)
> - Mechanism based PK modelling (e.g. enzyme induction/inhibition, =
> mediated drug disposition and complex absorption)
> - Mechanism based model building in therapeutic areas such as;
> neuroscience, haematology, diabetes, oncology, inflammation, =
> disease, respiratory disease and many more)
> - Translational modelling (e.g. pre-clinical to clinical and adult to
> paediatric populations)
> - Career advice for junior pharmacometricians
> - Pearl-Speaks-NONMEM (PsN) user support. Kajsa Harling, one of the =
> developers of PsN, is available to answer your questions.
> - R programming and reproducible reporting approaches
> If you want to read more about Pharmetheus’ consultants and =
> respective competences, please visit our website =
> Confidentiality agreements (CDA) will be arranged ahead of the meeting =
> the discussions that need that. Just make sure to indicate this as you
> sign up for a consultancy session on our website
> Note that if you judge a
> confidential disclosure agreement (CDA) is required, this may require =
> extra time to put in place ahead of the meeting. The deadline for
> applications is the 3rd of June and time slots will be communicated by =
> 10th of June. Please note that available time slots are limited. Sign =
> as soon as possible to give us a chance to help you tackle your
> challenges!
> We look forward to hear back from you, and to see you in Stockholm!
> The Pharmetheus Team
> Pharmetheus AB
> +46(0)18 513 328
> Uppsala Science Park
> Dag Hammarskjölds väg 36b, 2 tr
> 75237 Uppsala, Sweden

Received on Wed May 29 2019 - 11:03:02 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: